Ole A.
- Country
- Norway
- Department
- Nydalen DPS
Research Overview
- Phase 2 Randomized Delayed-Treatment Controlled Pilot Study of Oral Midomafetamine-Assisted Therapy in Young Adults with Chronic Treatment-Resistant Major Depressive Disorder
- Evaluation of Semaglutide as an Adjunctive Therapy for Metabolic Control in Patients with Schizophrenia Spectrum Disorders on Antipsychotics
Data & Insights
Has run more than one trial at 0 of 5 partner sites.
Specializations
Neurodevelopmental Disorders
This investigator specializes in studying autism spectrum disorders (ASD), with particular emphasis on evaluating novel therapeutic approaches for improving social behavior and neural plasticity in youth populations.
- Neural plasticity assessment
- Learning mechanisms in ASD
- Social behavior interventions
The research focus includes investigating innovative treatment modalities for addressing core symptoms of autism.
Metabolic Health
The investigator conducts research in metabolic control among patients using antipsychotic medications, particularly focusing on weight management strategies and metabolic parameters.
- Weight management interventions
- Metabolic syndrome
- Antipsychotic-related complications
Their work addresses the metabolic challenges faced by patients with psychiatric conditions requiring antipsychotic treatment.
Therapeutic Innovation
The investigator explores novel therapeutic applications in neuropsychiatric conditions, including the investigation of intranasal delivery systems and peptide therapeutics.
- Drug delivery systems
- Behavioral assessments
- Treatment optimization
Their research encompasses the evaluation of innovative therapeutic approaches for complex neuropsychiatric disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.